Femoxetine

Femoxetine

Systematic (IUPAC) name
(3R,4S)-3-[(4-methoxyphenoxy)methyl]-1-methyl-4-phenyl-piperidine
Clinical data
Pregnancy cat.	?
Legal status	Uncontrolled
Routes	Oral
Pharmacokinetic data
Half-life	7-27 hours
Identifiers
CAS number	59859-58-4
ATC code	None
PubChem	CID 3012003
ChemSpider	2280941 Y
UNII	8Y719ZLX8C Y
ChEMBL	CHEMBL94739 Y
Chemical data
Formula	C20H25NO2
Mol. mass	311.42 g/mol
SMILES	eMolecules & PubChem
InChI InChI=1S/C20H25NO2/c1-21-13-12-20(16-6-4-3-5-7-16)17(14-21)15-23-19-10-8-18(22-2)9-11-19/h3-11,17,20H,12-15H2,1-2H3/t17-,20-/m1/s1 Y Key:OJSFTALXCYKKFQ-YLJYHZDGSA-N Y
Y (what is this?)  (verify)

Femoxetine (Malexil, FG-4963) is a drug related to paroxetine that was being developed as an antidepressant by the pharmaceutical company Ferrosan in 1974. It functions as a selective serotonin reuptake inhibitor (SSRI). Development was halted for unknown reasons, perhaps to focus attention on paroxetine instead.

Dr. Jorgen Buus-Lassen of Ferrosan invented both femoxetine and paroxetine in the 1970s.